<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"adverse effects":2,
"dipeptidyl peptidase-4 inhibitors":1,
"glucagon-like peptide 1 receptor agonists":1,
"new antidiabetic agents":1,
"sodium-glucose cotransporter 2 inhibitors":1,
"antithyroglobulin antibody":2,
"difficulty":1,
"thyroidectomy":5,
"Iodine":1,
"Thyroid cancer":21,
"Thyroid nodules":5,
"cancer":6,
"coping":1,
"latina women":1,
"latino men":1,
"survivors":1,
"Clinical–histopathological features":1,
"Environmental factors":1,
"Tumourigenesis induction":1,
"Alcohol drinking":1,
"Case-control studies":1,
"Cohort studies":1,
"Meta-analysis":1,
"Thyroid neoplasms":12,
"ERα crosstalk":1,
"integrin αvβ3":2,
"ovarian cancer":1,
"thyroid hormone":1,
"Medullary thyroid cancer":3,
"biological behavior":1,
"prognosis":4,
"recurrence":4,
"ultrasonography":4,
"Combination":1,
"Contrast-enhanced ultrasound":1,
"Improved TI-RADS":1,
"TI-RADS":1,
"body fluid cytology":1,
"cell transfer":1,
"immunocytochemistry":1,
"immunohistochemistry":4,
"microarray":1,
"MGUS":1,
"Myeloma":1,
"Waldenström macroglobulinemia":1,
"secondary malignancies":1,
"Lateral neck node metastasis":1,
"Modified radical neck dissection":1,
"Oncologic outcome":1,
"Papillary thyroid cancer":7,
"Robotic surgery":1,
"Anaplastic thyroid carcinoma":1,
"Epithelial-mesenchymal transition":1,
"Neoplastic stem cells":1,
"Receptor Notch1":1,
"antigastric parietal cell antibody":1,
"antithyroid microsomal antibody":1,
"desquamative gingivitis":1,
"erosive oral lichen planus":1,
"BMI":1,
"Obesity":1,
"Papillary thyroid carcinoma":13,
"calcitonin":1,
"calcitonin gene–related peptide":1,
"neuroendocrine":1,
"thyroid":7,
"Parathyroid adenoma":1,
"Perrier classification":1,
"[99mTc]MIBI SPECT/CT":1,
"Granular cell tumour":1,
"Neurohypophysis":1,
"Pituicytoma":1,
"S100-protein":1,
"Spindle cell oncocytoma":1,
"TTF-1":1,
"Vimentin":1,
"99mTc-MIBI":1,
"Autonomously functioning thyroid nodules":1,
"Parathyroid carcinoma":1,
"Parathyroid scintigraphy":1,
"DNA laddering":1,
"apoptosis":4,
"cell cycle":2,
"cytotoxicity":1,
"organotin(IV) compounds":1,
"adverse reactions":1,
"intraoperative radiotherapy":1,
"pilot study":1,
"radiation therapy":1,
"18FDG PET/CT":1,
"Differentiated thyroid cancer":3,
"Metastases":1,
"Tumor growth rate":1,
"biological marker":1,
"programmed death-ligand 1":1,
"survival analysis":1,
"Anti-thyroglobulin autoantibodies":1,
"Positron emission tomography":1,
"Thyroglobulin":4,
"Aggressive":1,
"Family history":1,
"Hereditary":1,
"Medullary thyroid carcinoma":7,
"Multiple endocrine neoplasia 2":1,
"Arab":1,
"Breast":1,
"Mutation":2,
"TP53":1,
"disease-free survival":4,
"dynamic risk stratification":1,
"low risk":1,
"clinical significance":1,
"solid variant":1,
"Goitre":1,
"Medical diagnosis":1,
"Painting":1,
"de Ribera":1,
"fine-needle aspiration cytology":2,
"thyroid nodule":4,
"FN1":1,
"Invasion":4,
"SphK1":1,
"miR-144-3p":1,
"Extranodal invasion":1,
"Level I":1,
"Lymph node metastases":1,
"Neck dissection":3,
"discordant cancer":1,
"familial cancer":1,
"familial risk":1,
"population impact":1,
"American Thyroid Association":1,
"dynamic risk estimates":1,
"outcome":2,
"structural persistent disease":1,
"BAP1":1,
"China":1,
"IHC":1,
"Mesothelioma":1,
"Calcitonin amyloid (ACal)":1,
"amyloid-associated glomerulopathy":1,
"case report":1,
"decreased kidney function":1,
"kidney amyloidosis":1,
"nephrotic syndrome":1,
"proteinuria":1,
"renal biopsy":1,
"systemic amyloidosis":1,
"Cohort study":1,
"malignancy":2,
"osteoporosis":1,
"population-based":1,
"athyreotic patients":1,
"levothyroxine":1,
"thyrotropin":1,
"triiodothyronine":2,
"Cushing's syndrome":1,
"RET":2,
"hypercortisolism":1,
"vandetanib":1,
"computer-aided system":1,
"ultrasound":3,
"bone":1,
"neoplasm metastasis":1,
"131I":1,
"PARP-1":1,
"SLC6A9-5:2":1,
"lncRNA":1,
"basal cell carcinoma":1,
"deiodinases":1,
"thyroid hormone metabolism":1,
"immune-related adverse event":1,
"immunotherapy":3,
"ipilimumab":1,
"nivolumab":1,
"pembrolizumab":1,
"histopathology":1,
"hysterectomy":1,
"NIFTP":3,
"RAS":2,
"fine-needle aspiration":2,
"follicular variant of papillary thyroid carcinoma":1,
"molecular testing":2,
"ATA guidelines":1,
"Bethesda":2,
"FNA":2,
"cytology":2,
"ultrasound needle biopsy":1,
"ATC":1,
"Migration":2,
"PIK3CD":1,
"miR-125b":1,
"active surveillance":2,
"overdiagnosis":2,
"Children":1,
"Nodule":1,
"Lifestyle":1,
"Rosacea":1,
"Skin disease":1,
"follicular variant":2,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"radioactive iodine":2,
"distant metastasis":1,
"long-term":1,
"temporal pattern":1,
"Adverse event":1,
"Dose interruption":1,
"Dose reduction":1,
"Lenvatinib":3,
"aggressive phenotype":1,
"antibody-drug conjugate":1,
"dysadherin":1,
"treatment":1,
"ADC to SCC transdifferentiation":1,
"S100A7":1,
"YAP":1,
"lung cancer cells":1,
"the Hippo pathway":1,
"Cell migration":1,
"Cell viability":1,
"Doxorubicin":1,
"Resistance":1,
"Thyroid carcinoma":9,
"PKA Cα":1,
"cell proliferation":1,
"p21-activated kinase 4":1,
"thyroid-stimulating hormone":1,
"Afirma":1,
"Bethesda classification":1,
"atypia of undetermined significance (AUS)":1,
"follicular lesion of undetermined significance (FLUS)":1,
"malignancy risk":1,
"C-cell carcinogenicity":1,
"GLP-1r agonists":1,
"PKPD modelling":1,
"Pharmacology":1,
"Prediction":1,
"Bone morphogenetic protein 4":1,
"Tumor progression":1,
"EFVPTC":1,
"Endocrine":1,
"Follicular neoplasm":1,
"HBME-1":1,
"Spindled lesion":1,
"fine needle aspiration":2,
"thyroid papillary microcarcinoma":1,
"BRAF":2,
"RET/PTC":1,
"TERT promoter":1,
"disease-specific survival":1,
"genetic alteration":1,
"rearrangement":1,
"relapse":1,
"survival":3,
"FOXO3a":1,
"Proteasome inhibitor MG132":1,
"Papillary thyroid carcinoma variant":1,
"Thyroid cancer, papillary":1,
"TCGA data":1,
"VDR mRNA":1,
"vitamin D":1,
"anaplastic":2,
"follicular":1,
"medullary":1,
"papillary":2,
"patient-reported outcomes":1,
"quality of life":1,
"lymph node":2,
"metastasis":4,
"skip metastasis":1,
"Biomarkers":2,
"Clinical trial":1,
"Phase 3":1,
"Tyrosine kinase inhibitor":1,
"Head and Neck Neoplasms":1,
"Incidental Findings":1,
"Thyroid tumours":1,
"molecular":1,
"morphology":1,
"ITIH5":1,
"Metastasis suppressor":1,
"Pancreatic cancer":1,
"RNAi screen":1,
"Anatomy pathology":1,
"Intra-thyroid metastasis":1,
"Métastase intra-thyroïdienne, Anatomie-pathologie, Immunohistochimie":1,
"2017":1,
"Forecasting":1,
"Incidence":1,
"Korea":1,
"Mortality":1,
"Neoplasms":1,
"cribriform-morular":1,
"papillary carcinoma":4,
"review":1,
"CEACAM1":1,
"SHP-1":1,
"Src family kinases":1,
"mast cell":1,
"Hypothyroidism":3,
"Predictive factor":1,
"Progression-free survival":1,
"Renal cell carcinoma":1,
"Sunitinib":1,
"adrenocortical carcinoma":1,
"daganat-biomarker":1,
"mellékvesekéreg-carcinoma":1,
"microRNA":1,
"mikroRNS":1,
"ovarian neoplasm":1,
"pajzsmirigydaganat":1,
"petefészek-daganat":1,
"thyroid neoplasm":1,
"tumor biomarker":1,
"PD-L1":2,
"PTC":1,
"Protein biomarker":1,
"Anastomosing channels":1,
"metastasis, miR-199a-3p":1,
"Afirma® Gene Expression Classifier":1,
"Indeterminate thyroid nodules":1,
"Ultrasound-guided fine-needle aspiration":1,
"Bax/BcL-2 ratio":1,
"Myricetin":1,
"human anaplastic thyroid cancer cells":1,
"ATM":1,
"Breast tumor resembling tall cell variant of papillary thyroid carcinoma":1,
"CK5":1,
"ER":1,
"IDH2":1,
"Myoepithelial markers":1,
"PIK3CA mutations":1,
"Reverse nuclear polarity":1,
"Solid papillary neoplasm":1,
"Lymph node size":1,
"Ratio of lymph node":1,
"Risk stratification":1,
"Serological markers":1,
"Thyroid malignancy":1,
"Thyroxine":1,
"fine-needle-aspiration":1,
"non-specific adsorption":1,
"washout":1,
"Protein tyrosine phosphatase 1B (PTP1B)":1,
"Signal transduction and activator of transcription 3 (STAT3)":1,
"Breast cancer":4,
"Tumorigenesis":2,
"cell cycle progression":1,
"proliferation":3,
"protein arginine methyltransferase 5":1,
"fine needle aspiration cytology (FNAC)":1,
"gene expression classifier":1,
"indeterminate lesions":1,
"microRNAs (miRNAs)":1,
"next generation sequencing":1,
"radiotherapy":2,
"Endoscopic dacryocystorhinostomy":1,
"nasolacrimal duct obstruction":1,
"SURGERY":2,
"hypoxia inducible factor 1 alpha":1,
"oncology":2,
"tissue microarray":1,
"fucosidase":1,
"glycosylation":1,
"Appraisal":1,
"Healthcare decisionmaking":1,
"Mcda":1,
"CC":1,
"PKM2":1,
"miR-let-7a":1,
"Lymphoma":1,
"Sjögren syndrome":1,
"ADC histogram analysis":1,
"Ki-67":1,
"diffusion weighted imaging":1,
"histopathologic features":1,
"lymphatic metastatic spread":1,
"p53":1,
"Nanostring":1,
"RET/PTC gene rearrangement":1,
"RT-PCR":1,
"air-dried FNA specimen":1,
"Consumptive hypothyroidism":1,
"Hemangioma":1,
"Liothyronine":1,
"Type 3 deiodinase":1,
"Goitre, Hyperthyroidism, Hypothyroidism, Thyroid nodules":1,
"GATA":1,
"chemosensitivity":1,
"database mining":1,
"prognostic values":1,
"SEER":1,
"breast cancer subtypes":1,
"distant metastases":1,
"ST8SIA4":1,
"follicular thyroid carcinoma":1,
"miR-146a":1,
"miR-146b":1,
"Colon cancer":1,
"Rectal cancer":1,
"Thyroid metastasis":1,
"BRCA1":1,
"Hereditary breast cancer":1,
"Peroxisome-proliferator activated Receptor γ (PPARγ)":1,
"Retinoid X Receptor (RXR)":1,
"Vitamin D Receptor (VDR)":1,
"funding":1,
"global burden of disease":1,
"global health":1,
"research and development":1,
"research investment":1,
"hormones":1,
"lungs":1,
"sex-related differences":1,
"tumor":1,
"Risk of malignancy":1,
"Total thyroidectomy":1,
"Lymph node between sternocleidomastoid and sternohyoid muscle":1,
"Risk factors":2,
"Carcinoma, papillary":2,
"Postoperative complications":1,
"Reoperation":1,
"Lymphatic metastasis":1,
"Previvors":1,
"Practice guidelines":1,
"Endodermal sinus tumor":1,
"Malignant tumor":1,
"Pleuropulmonary blastoma":1,
"Squamous cell carcinoma of lung":1,
"Thyroid papillary carcinoma":1,
"Hurthle cell":2,
"Metastatic lymph node":1,
"Hashimoto’s disease":1,
"Hashimoto’s thyroiditis":1,
"autoimmune thyroid disease":1,
"autoimmune thyroiditis":1,
"cancer genes":1,
"lipid metabolism":1,
"radiation":1,
"Pi3K":1,
"combination treatment":1,
"genetically engineered mice":1,
"15-deoxy-Δ12,14-prostaglandin J2":1,
"adherens junction":1,
"focal adhesion complex":1,
"cluster of differentiation 26":1,
"glucagon-like peptide-1 receptor":1,
"thyroid C-cell":1,
"Cutoff":1,
"Fine-needle aspirate":1,
"diagnosis":3,
"Cutaneous adenoid cystic carcinoma":1,
"Lung metastases":1,
"Thyroid transcription factor 1":1,
"Genetic":1,
"genotype-phenotype correlation":1,
"multiple endocrine neoplasia type 2":1,
"neurofibromatosis type 1":1,
"paraganglioma":1,
"von Hippel-Lindau disease":1,
"embolization":1,
"hypervascular":1,
"metastases of unknown origin":1,
"preoperativve":1,
"spinal cord compression":1,
"spinal metastases":1,
"spine surgery":1,
"thoracic":1,
"thyroid follicular carcinoma":1,
"chemotherapy":1,
"imaging":1,
"management":1,
"pathology":1,
"radioiodine":1,
"HER2/neu":1,
"PLA2G16":1,
"autoantigens":1,
"autoimmunity":1,
"central nervous system":1,
"immune repertoire":1,
"immunological homunculus":1,
"natural autoantibodies":1,
"paraneoplastic syndrome":1,
"synapse":1,
"Hurthle cell adenoma":1,
"PET/MRI":1,
"PSMA":1,
"prostate carcinoma":1,
"Iodine-123 metaiodobenzylguanidine":1,
"multiple endocrine neoplasia":1,
"pheochromocytoma":1,
"rearranged during transfection":1,
"Bifrontal craniotomy":1,
"Dura":1,
"Meningioma":2,
"Scalp":1,
"parathyroidectomy":1,
"primary hyperparathyroidism":1,
"BMT":1,
"clinical decision making":1,
"follicular lymphoma":1,
"positron emission tomography with computed tomography":1,
"thyroid incidentaloma":1,
"Lymph vessels":1,
"Medullary carcinoma":1,
"Follicular carcinoma":1,
"Nodule in nodule":1,
"amphioxus":1,
"glycoprotein hormone":1,
"thyroid gland":1,
"thyrostimulin":1,
"Endoscopic":1,
"Minimally invasive":1,
"Neurosurgery":1,
"Transsphenoidal":1,
"Struma ovarii":1,
"malignant ovarian goiter":1,
"NEM2A":1,
"NEM2B":1,
"HABP2":1,
"non-medullary thyroid cancer":1,
"p G534E":1,
"sporadic papillary thyroid carcinoma":1,
"NSCLC":2,
"histologic type":1,
"prognostic factor":1,
"RGD peptide":1,
"lung cancer":2,
"osteolytic metastasis":1,
"targeted imaging":1,
"carcinoid":1,
"gastroenteropancreatic neuroendocrine tumors":1,
"neuroendocrine tumor":1,
"octreotide":1,
"pNET":1,
"radiolabeled therapy":1,
"somatostatin analogues":1,
"Autoimmune":1,
"Blood Coagulation Factors":1,
"Fibrinolysis":1,
"Hashimoto Disease":1,
"Hyperthyroidism":1,
"Myxedema":1,
"Thyroiditis":2,
"Venous Thromboembolism":1,
"Diethylnitrosamine":1,
"Mouse model":1,
"HLA class I antigens":1,
"Immune checkpoint":1,
"NIBIT 2016":1,
"Targeted therapy":1,
"Fluorescence intensity":1,
"Gastric cancer":1,
"Indocyanine green":1,
"Near-infrared fluorescence imaging":1,
"Sentinel node navigation surgery":1,
"Bone metastases":1,
"Fractura patológica":1,
"Lesiones líticas":1,
"Lytic lesions":1,
"Metástasis óseas":1,
"Pathological fracture":1,
"Colorectal cancer":1,
"STAT3":1,
"lnc-DILC":1,
"hsa-miR-193b":1,
"laryngal neoplasms":1,
"squamous cell carcinoma":1,
"APC gene":1,
"breast implants":1,
"cribriform-morular papillary thyroid carcinoma":1,
"familial adenomatous polyposis":1,
"fibromatosis":1,
"β-catenin":1,
"Carcinoma thyroid":1,
"I-131 isolation rooms":1,
"lead glass window":1,
"stray radiations":1,
"Immune checkpoint inhibitors":1,
"Thyrotoxicosis":1,
"Toxicity":1,
"Tyrosine kinase inhibitors":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2017年4月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
